COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD
C Mihai, R Dobrota, M Schröder, A Garaiman… - Annals of the …, 2020 - ard.bmj.com
During the current global outbreak of coronavirus disease 2019 (COVID-19), risk
stratification of patients is of utmost importance. Currently, patients> 65 years and those with …
stratification of patients is of utmost importance. Currently, patients> 65 years and those with …
[PDF][PDF] The hospital anxiety and depression scale in patients with systemic sclerosis: a psychometric and factor analysis in a monocentric cohort
A Garaiman, C Mihai, R Dobrota, S Jordan… - Clin Exp …, 2021 - clinexprheumatol.org
Objective. To evaluate the feasibility, validity, reliability, and responsiveness of the Hospital
Anxiety and Depression Scale (HADS) and to analyse its model structure in patients with …
Anxiety and Depression Scale (HADS) and to analyse its model structure in patients with …
Vision transformer assisting rheumatologists in screening for capillaroscopy changes in systemic sclerosis: an artificial intelligence model
A Garaiman, F Nooralahzadeh, C Mihai… - …, 2023 - academic.oup.com
Objectives The first objective of this study was to implement and assess the performance
and reliability of a vision transformer (ViT)-based deep-learning model, an 'off-the …
and reliability of a vision transformer (ViT)-based deep-learning model, an 'off-the …
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire
MO Becker, R Dobrota, A Garaiman… - Annals of the …, 2022 - ard.bmj.com
Objectives Patient-reported outcome measures (PROMs) are important for clinical practice
and research. Given the high unmet need, our aim was to develop a comprehensive PROM …
and research. Given the high unmet need, our aim was to develop a comprehensive PROM …
Cellular determinants involving mitochondrial dysfunction, oxidative stress and apoptosis correlate with the synergic cytotoxicity of epigallocatechin-3-gallate and …
We have investigated the growth-suppressive action of epigallocatechin-3-gallate (EGCG)
on human leukemia Jurkat T cells. Results show a strong correlation between the dose …
on human leukemia Jurkat T cells. Results show a strong correlation between the dose …
[HTML][HTML] Detailed analysis of apoptosis and delayed luminescence of human leukemia Jurkat T cells after proton irradiation and treatments with oxidant agents and …
I Baran, C Ganea, S Privitera, A Scordino… - … medicine and cellular …, 2012 - hindawi.com
Following previous work, we investigated in more detail the relationship between apoptosis
and delayed luminescence (DL) in human leukemia Jurkat T cells under a wide variety of …
and delayed luminescence (DL) in human leukemia Jurkat T cells under a wide variety of …
[HTML][HTML] The incremental value of the contribution of a biostatistician to the reporting quality in health research—A retrospective, single center, observational cohort …
U Held, K Steigmiller, M Hediger, VL Cammann… - Plos one, 2022 - journals.plos.org
Background The reporting quality in medical research has recently been critically discussed.
While reporting guidelines intend to maximize the value from funded research, and …
While reporting guidelines intend to maximize the value from funded research, and …
Mitochondrial respiratory complex I probed by delayed luminescence spectroscopy
The role of mitochondrial complex I in ultraweak photon-induced delayed photon emission
[delayed luminescence (DL)] of human leukemia Jurkat T cells was probed by using …
[delayed luminescence (DL)] of human leukemia Jurkat T cells was probed by using …
[HTML][HTML] The enigma of mixed connective tissue disease—challenges in routine care
A Wanzenried, A Garaiman, S Jordan, O Distler… - Clinical …, 2022 - Springer
Objectives As a rare and heterogeneous disease, mixed connective tissue disease (MCTD)
represents a challenge. Herein, we aimed to unravel potential pitfalls including correct …
represents a challenge. Herein, we aimed to unravel potential pitfalls including correct …
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model
Objective To develop and validate the prognostic prediction model DU-VASC to assist the
clinicians in decision-making regarding the use of platelet inhibitors (PIs) for the …
clinicians in decision-making regarding the use of platelet inhibitors (PIs) for the …